MedTech’s Got Talent 2018 – applications now open
Australia’s premier early stage MedTech challenge is seeking Australia’s aspiring next generation MedTech entrepreneurs and innovators. Now in its fifth and largest year, MedTech’s Got Talent has opened its 2018 application round. Top teams win a share in over…
Read MoreWhat to do when an R&D tax incentive claim goes bad
The R&D tax incentive program is the Government’s largest program designed to support business innovation. It has been reviewed multiple times, with each review concluding it provides significant benefits to the Australian economy, far beyond the cost. AusIndustry…
Read MoreLocation, location, translation: key messages from the Biotech Development Lab
Last Friday, BioMelbourne Network hosted the Molecules, Medicines and Markets Biotech Development Lab. One of our volunteers, Emma Wanicek, wrote the following summary of the event. Emma is a Research Assistant in the HIV Neuropathogenesis Laboratory in the Chronic Infectious and…
Read MoreSienna appoints exclusive distribution partner for mainland China
Sienna Cancer Diagnostics Ltd has appointed Shaanxi GaoYuan In Vitro Diagnostic Reagents Co. (“GaoYuan”) as the Company’s exclusive distribution partner for mainland China. The distribution agreement for mainland China is a milestone in Sienna’s geographical expansion strategy. The agreement…
Read MoreImmutep TACTI-mel patient recruitment completed, operational update & Canadian IMP731 patent
Immutep today reports in its operational update that the final patient in Part B of the ongoing TACTI-mel Phase I clinical trial in Australia has now been recruited and is receiving treatment. Patients will be treated for up…
Read MoreBioMelbourne Network submission regarding R&D Tax Incentive
August 2018 On behalf of the members, BioMelbourne Network has made a submission to Treasury regarding the proposed changes to the R&D Tax Incentive. In terms of our overall consideration of the proposed changes to the R&D Tax…
Read MoreBioCurate launches first round of project investments
BioCurate Pty Ltd has achieved an important milestone announcing investments in six early drug discovery projects from research groups at The University of Melbourne and Monash University. These projects represent the first tranche of investments for BioCurate: Dr…
Read More
